Company Name: Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development of gene control medicines using its proprietary gene control platform. The company’s areas of focus include cancer and immune-mediated diseases.
Ticker Symbol: SYRS (NASDAQ)
Company Website: http://syros.com/
Headquarters: Cambridge, Massachusetts